Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

Share Price is delayed by 15 minutes
Get Live Data
39.30    -1.95 (-4.73%)
Bid:
39.15
Ask:
39.40
Spread: 0.25 (0.639%)
Market Cap: £515.85m
IQE Live PriceLast checked at - London Stock Exchange

Intraday IQE Share Chart

Form 8.3 IQE PLC Replacement

13 Apr 2026 07:27

RNS Number : 0808A
Barclays PLC
13 April 2026
 

FORM 8.3 - Amendment - this form replaces RNS number 8673Z published at 13:43 on 09/04/2026, changes made to section 2a and 3b

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

 

Barclays PLC.

(b)

Owner or controller of interest and short

 

 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

IQE PLC

 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

 

 

offeror/offeree, state this and specify identity of

 

offeror/offeree:

(e)

Date position held/dealing undertaken:

08 Apr 2026

(f)

In addition to the company in 1(c) above, is the discloser making

NO

 

 

 

disclosures in respect of any other party to the offer?

 

 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

 

 

to which the disclosure relates following the dealing(if any)

 

Class of relevant security:

1p ordinary

 

Interests

Short Positions

 

Number

(%)

Number

(%)

(1)

Relevant securities owned

 

 

 

 

 

and/or controlled:

 

 

504,590

0.05%

9,841,371

1.01%

(2)

Cash-settled derivatives:

 

 

 

 

 

 

 

 

10,026,806

1.02%

690,024

0.07%

(3)

Stock-settled derivatives (including options)

 

 

 

 

 

and agreements to purchase/sell:

 

 

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

 

TOTAL:

 

 

10,531,396

1.08%

10,531,395

1.08%

(b)

Rights to subscribe for new securities (including directors and other executive

 

 

options)

 

 

 

 

 

 

Class of relevant security in relation to

 

 

 

 

which subscription right exists

 

 

 

 

Details, including nature of the rights

 

 

 

 

concerned and relevant percentages:

 

 

 

 

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchases and sales

 

 

 

 

 

Class of relevant

Purchase/sale

Number of

Price per unit

security

 

securities

 

1p ordinary

Purchase

582,595

0.2830 GBP

1p ordinary

Purchase

490,047

0.2813 GBP

1p ordinary

Purchase

452,877

0.2807 GBP

1p ordinary

Purchase

418,095

0.2822 GBP

1p ordinary

Purchase

216,754

0.2821 GBP

1p ordinary

Purchase

177,387

0.2810 GBP

1p ordinary

Purchase

174,177

0.2870 GBP

1p ordinary

Purchase

172,619

0.2736 GBP

1p ordinary

Purchase

36,652

0.2831 GBP

1p ordinary

Purchase

55

0.2867 GBP

1p ordinary

Sale

592,806

0.2870 GBP

1p ordinary

Sale

243,702

0.2854 GBP

1p ordinary

Sale

241,316

0.2834 GBP

1p ordinary

Sale

216,533

0.2847 GBP

1p ordinary

Sale

207,920

0.2821 GBP

1p ordinary

Sale

135,387

0.2807 GBP

1p ordinary

Sale

45,100

0.2776 GBP

1p ordinary

Sale

37,892

0.2857 GBP

1p ordinary

Sale

28,000

0.2822 GBP

1p ordinary

Sale

14,000

0.2820 GBP

1p ordinary

Sale

8,834

0.2840 GBP

 

 

 

 

 

 

 

 

(b)

Cash-settled derivative transactions

 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

 

reference

unit

security

 

 

securities

 

1p ordinary

SWAP

Increasing Long

45,100

0.2776 GBP

1p ordinary

SWAP

Increasing Long

241,316

0.2834 GBP

1p ordinary

SWAP

Increasing Long

5,050

0.2844 GBP

1p ordinary

SWAP

Increasing Long

202,112

0.2846 GBP

1p ordinary

SWAP

Increasing Long

9,371

0.2869 GBP

1p ordinary

SWAP

Increasing Long

118,933

0.2870 GBP

1p ordinary

SWAP

Decreasing Long

38,683

0.2700 GBP

1p ordinary

SWAP

Decreasing Long

452,877

0.2807 GBP

1p ordinary

SWAP

Decreasing Long

418,095

0.2822 GBP

1p ordinary

SWAP

Decreasing Long

573,089

0.2829 GBP

1p ordinary

SWAP

Decreasing Long

36,652

0.2831 GBP

1p ordinary

SWAP

Decreasing Long

9,506

0.2854 GBP

1p ordinary

SWAP

Decreasing Long

55

0.2867 GBP

1p ordinary

SWAP

Decreasing Long

48

0.2870 GBP

1p ordinary

CFD

Increasing Long

37,892

0.2857 GBP

1p ordinary

CFD

Increasing Long

61,102

0.2869 GBP

1p ordinary

CFD

Increasing Long

391,053

0.2870 GBP

1p ordinary

CFD

Increasing Long

6,495

0.2885 GBP

1p ordinary

CFD

Decreasing Long

490,047

0.2813 GBP

1p ordinary

CFD

Decreasing Long

49,140

0.2828 GBP

 

 

 

 

 

 

 

 

(c)

Stock-settled derivative transactions (including options)

 

(i)

Writing, selling, purchasing or varying

 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

 

date

money

relevant

 

selling,

securities

per unit

 

 

paid/

security

 

varying etc

to which

 

 

 

received

 

 

 

option

 

 

 

per unit

 

 

 

relates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii)

Exercise

 

 

 

 

 

 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

 

 

securities

unit

 

 

 

 

 

 

 

 

 

 

 

 

 

(d)

Other dealings (including subscribing for new securities)

 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

 

 

applicable)

 

 

 

 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

 

 

formal or informal, relating to relevant securities which may be an inducement to deal

 

 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

 

to the offer or any person acting in concert with a party to the offer:

 

 

 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

 

 

the person making the disclosure and any other person relating to:

 

 

(i) the voting rights of any relevant securities under any option; or

 

 

 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

 

 

any derivative is referenced:

 

 

 

 

 

 

NONE

(c)

Attachments

 

 

 

 

 

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

13 Apr 2026

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETITMLTMTMBMTF
Date   Source Headline
29th Nov 20168:04 amRNSIQE and BLUGLASS announce strategic partnership
17th May 20167:00 amRNSIQE news update from CS-Mantech conference
16th May 20167:00 amRNSIQE Joins imec's GaN-on-Si Program
19th Apr 20167:16 amRNSIQE joins EUR15m project
17th Feb 20167:05 amRNSProfessor Colin Whitehouse appointed as CSC Chair
8th Jan 20167:01 amRNSCompound Semiconductor Catapult Centre announced
7th Oct 20157:00 amRNSIQE's GaN on Si achieves breakthrough results
30th Jul 201511:00 amRNSIQE key partner in US Integrated Photonics program
21st Apr 20157:00 amRNSIncreasing demand for IQE's Infrared products
31st Mar 20147:00 amRNS200mm GaN on Silicon for next generation CMOS
19th Mar 20147:00 amRNSIQE delivers 150mm (6") VCSEL epiwafers
13th Mar 20147:00 amRNSIQE's VCSEL wafers enable record performance
11th Mar 20147:20 amRNSPresentation at OFC
22nd Aug 20137:00 amRNSIQE reports new CPV cell efficiency
5th Jun 20132:22 pmRNSMerger Update
8th Mar 20133:00 pmRNSMerger Update
8th Jan 20138:39 amRNSStatement regarding press articles
31st Jul 20123:54 pmRNSDirectorate Change
10th Apr 20125:11 pmRNSDirector Dealings
27th Mar 20122:00 pmRNSPartnership Agreement
8th Feb 20124:10 pmRNSCompletion of Placing
17th Feb 20103:56 pmRNSNominated Adviser Change of Name
7th Aug 20094:42 pmRNSHolding(s) in Company
7th Aug 20094:30 pmRNSBondholders meeting
7th Aug 20093:51 pmRNSDirector Dealing in Shares
12th Jun 20081:42 pmRNSAdditional Listing
15th Apr 20087:01 amRNSAdditional Listing
7th Apr 200812:14 pmRNSDirector/PDMR Shareholding
28th Mar 200811:52 amRNSDirector/PDMR Shareholding
19th Mar 20087:00 amRNSDirector/PDMR Shareholding
17th Mar 20081:00 pmRNSContract Win
17th Mar 20087:01 amRNSFinal Results
28th Feb 20083:27 pmRNSHolding(s) in Company
19th Feb 20088:30 amRNSNotice of Results
25th Jan 20087:00 amRNSBank Facilities
17th Jan 20087:00 amRNSTrading Update
16th Jan 200811:15 amRNSBroker Appointment
15th Jan 200812:12 pmRNSDirector/PDMR Shareholding
9th Jan 20084:26 pmRNSAdditional Listing
7th Jan 20087:00 amRNSDirector/PDMR Shareholding
4th Jan 200812:46 pmRNSHolding(s) in Company
19th Dec 20077:30 amRNSAdditional Listing
18th Dec 20073:52 pmRNSSubstrate supply contract
13th Dec 20077:01 amRNSSuccessful Qualifications
9th Nov 200710:53 amRNSDirector/PDMR Shareholding
3rd Oct 200710:41 amRNSDirector/PDMR Shareholding
1st Oct 20072:44 pmRNSAdditional Listing
28th Sep 200710:14 amRNSContract Win
28th Sep 20078:12 amRNSInvestor Presentation
4th Sep 200712:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.